You are here: / / SuperGen Receives FDA Clearance to Initiate Phase I Clinical Trial With...

SuperGen Receives FDA Clearance to Initiate Phase I Clinical Trial With MP470

/in ,

SuperGen Receives FDA Clearance to Initiate Phase I Clinical Trial With MP470

2007_Comparison of AT7519 in Solid Tumor and Hematological Cell LinesSuperGen to Release 2007 First Quarter Financial Results May 2